Zobrazeno 1 - 10
of 201
pro vyhledávání: '"J.-P. Bader"'
Publikováno v:
Proceedings of the International Association of Hydrological Sciences, Vol 383, Pp 255-260 (2020)
In semi-arid regions, the annual floods of alluvial plains, wetlands and lakes provide essential services to millions of farmers, livestock holders and fishers. The scale, number and dispersion of these water bodies limit however their hydrological u
Externí odkaz:
https://doaj.org/article/128683fa648a4990bc1344a6b1097b18
Publikováno v:
Oncologie. 11:95-100
The generalization of colorectal cancer prevention cam- paigns leads inevitably to the multiplication of control colonos- copies, for those patients who have been treated by endoscopic removal of precancerous lesions. Risk of recurrence varies accord
Autor:
Didier Guillemot, Georges France, Pierre Fender, J.-M. Alexandre, O. Amede-Manesme, J.-P. Bader, M. Bouhassira, B. Calles, A. Castaigne, M. Chauvenet, B. Diquet, I. Giri, F. Ichou, P. Jolliet, J.-M. Joubert, J.-P. Lehner, M. Lièvre, H. Mathiex-Fortunet, M. Marty, F. Meyer, J. Micallef, M. Pigeon, B. Rouveix, F. Zannad
Publikováno v:
Therapies. 60:359-362
Resume Des lors qu’un nouveau medicament est susceptible d’etre commercialise, la question de l’evaluation du progres therapeutique se pose en deux temps. Tout d’abord quelle est la quantite de progres therapeutique attendu ? Ce premier temps
Autor:
Didier Guillemot, Georges France, Pierre Fender, J.-M. Alexandre, O. Amede-Manesme, J.-P. Bader, M. Bouhassira, B. Calles, A. Castaigne, M. Chauvenet, B. Diquet, I. Giri, F. Ichou, P. Jolliet, J.-M. Joubert, J.-P. Lehner, M. Lièvre, H. Mathiex-Fortunet, M. Marty, F. Meyer, J. Micallef, M. Pigeon, B. Rouveix, F. Zannad
Publikováno v:
Therapies. 60:363-366
When a candidate drug is likely to become available to prescribers and healthcare policy makers, evaluation of therapeutic progress moves forward in two stages. First, the level of expected therapeutic progress must be established. This first stage r
Autor:
Marie Fouchard, Faiez Zannad, E. Autret-Leca, J.-P. Bader, M. Bellet, J.-F. Bergmann, M. Bernard-Harlaud, C. Bernaud, R. Bordet, G. Bouvenot, C. Brun-Strang, A. Castaigne, N. Dumarcet, E. Eschwège, M. Gallard, I. Giri, B. Hamelin, A. Jeanblanc, P. Jolliet, H. Kolsky, D. Lagarde, G. Lapeyre, C. Lassale, J.-P. Lehner, H. Lelouët, M. Malbezin, S. Paulmier-Bigot, M. Pigeon, S. Ravoire, P. Ricordeau, B. Rouveix, J. Soletti, S. Tardieu, J.-L. Thomas, C. Thuillez
Publikováno v:
Therapies. 59:323-328
The round table elected to focus its discussion on trials that, in terms of their importance, are likely to modify medical practices and behaviour. Such trials may be pre- or postmarketing studies. For the findings of a trial to result in a change in
Autor:
Marie Fouchard, Faiez Zannad, E. Autret-Leca, J.-P. Bader, M. Bellet, J.-F. Bergmann, M. Bernard-Harlaud, C. Bernaud, R. Bordet, G. Bouvenot, C. Brun-Strang, A. Castaigne, N. Dumarcet, E. Eschwège, M. Gallard, I. Giri, B. Hamelin, A. Jeanblanc, P. Jolliet, H. Kolsky, D. Lagarde, G. Lapeyre, C. Lassale, J.-P. Lehner, H. Lelouët, M. Malbezin, S. Paulmier-Bigot, M. Pigeon, S. Ravoire, P. Ricordeau, B. Rouveix, J. Soletti, S. Tardieu, J.-L. Thomas, C. Thuillez
Publikováno v:
Therapies. 59:317-322
Resume La table ronde a choisi d’orienter sa discussion sur les essais qui, par leur importance, sont susceptibles de modifier les pratiques medicales et les comportements. Ces essais peuvent etre pre- ou post-AMM (autorisation de mise sur le march
Publikováno v:
Fortschritte der Neurologie · Psychiatrie. 68:158-168
In a review of the relevant literature the experience of pain in depression is emphasized. There is evidence for a central pain disturbance mediating the 'psychic pain' experience in severe major depressive episodes with a predominance of anxiousness
Autor:
Valerie Fliakas-Boltz, Murray Zanger, T. N. Khan, M J Snow, Julie Russell, Luke A. Pallansch, S. S. Yang, J. P. Bader, Robert W. Buckheit
Publikováno v:
Antiviral Chemistry and Chemotherapy. 7:243-252
Structure-activity relationship evaluations with a series of diarylsulphone non-nucleoside reverse transcriptase (RT) inhibitors indicated that the steric properties of the molecule and compound lipophilicity primarily contributed to the overall leve
Publikováno v:
ChemInform. 26